
Add to Cart
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection
Clinical Use
Accurate rapid diagnostic tests for SARS-CoV-2 infection could contribute to clinical and public health strategies to manage the COVID-19 pandemic. Point-of-care antigen and molecular tests to detect current infection could increase access to testing and early confirmation of cases, and expediate clinical and public health management decisions that may reduce transmission.
Main Components
Test Cassettes
Sample tubes
Extraction Buffer
Swabs
Tube stand
Instruction for use
Package specification
1T/Box,5T/Box
Product Feature
High accuracy, specificity and sensitivity
Detectino of mutations
Safety and Reliability
Simple operation, No extra instrument
Results in 15minutes and easy to read
Intend Use
This rapid test kit is designed to qualitatively detect the SARS-CoV-2 virus nucleocapsid antigen from the nasal secretions of individuals suspected of COVID-19.
Use Step
Result Interpretation
POSITIVE: Two colored bands appear on the membrane. One band appears in the control region (C) and another band appears in the test region (T).
NEGATIVE: Only one colored band appears, in the control region (C). No apparent colored band appears in the test region (T).
INVALID: If there is no Control line (C) or only a Test line (T) in the result window, the test did not run correctly and the results are not valid.
Virus Sources
Global high frequency mutation | Alpha / B.1.1.7(U.K.) | Beta I B.1.351(South Africa) |
Gemma I P.1(Brazil) | Kappa I B.1.617.1(India) | Delta I B.1.617.2(India) |
C.37,ect | Alpha I B.1.17(U.K.) | B.1.36.16.etc |
A.2.5,etc | A.23.1 | Alpha I B.1.17(U.K.) |
B.1.1.33.etc | C.1.1.etc. |
Certificate (CE approved)